Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics is a research paper published in Current Atherosclerosis Reports (2021). On theSindex it has a DataRank of 0.621. It has been cited 62 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32 HL094301.
National Institutes of Health
Grant: R35HL144993
National Institutes of Health
Grant: R01HL139909
National Institutes of Health
Grant: K23 HL152013
National Psoriasis Foundation
Grant: Bridge Grant
American Heart Association
Grant: 18CDA34080540
National Institutes of Health
Grant: 5T32HL094301-08
Noninvasive Cardiovascular Imaging Research Training Program
National Institutes of Health
Grant: 5R01HL139909-02
Platelet Activity and Vascular Health in Systemic Lupus Erythematosus
National Institutes of Health
Grant: 5K23HL152013-03
Endovascular Health and Platelet Activity in Psoriasis
National Institutes of Health
Grant: 5R35HL144993-04
Mechanisms of Platelet Activity in Vascular Disease
FWCI
2.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals